pG2 gene expression and its regulation in human adrenocortical and medullary tumors.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10366415)

Published in Eur J Endocrinol on June 01, 1999

Authors

J Liu1, R Voutilainen, P Heikkilä, A I Kahri

Author Affiliations

1: Department of Pathology, PO Box 21, University of Helsinki, FIN-00014 Helsinki, Finland.

Articles by these authors

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol (1999) 3.09

Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med (2001) 2.76

Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res (1998) 2.60

Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34

Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest (1999) 2.06

Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res (2000) 1.97

Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc Natl Acad Sci U S A (1986) 1.88

Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet (1998) 1.85

Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol (1999) 1.68

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol (1998) 1.61

Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res (1999) 1.61

Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child (1999) 1.50

Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol (1999) 1.44

Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer (1997) 1.40

The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene (2007) 1.39

Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17 alpha-hydroxylase/17,20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab (1986) 1.33

High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer (2009) 1.33

Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ Health (1991) 1.23

Statistical modelling of the determinants of historical exposure to bitumen and polycyclic aromatic hydrocarbons among paving workers. Ann Occup Hyg (2000) 1.21

Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. J Biol Chem (1988) 1.21

Significance of dermal and respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene. Occup Environ Med (1995) 1.21

Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19

Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology (1991) 1.15

Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum Mol Genet (1997) 1.15

Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J (1996) 1.14

Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol (1997) 1.13

Developmental expression of genes for the stereoidogenic enzymes P450scc (20,22-desmolase), P450c17 (17 alpha-hydroxylase/17,20-lyase), and P450c21 (21-hydroxylase) in the human fetus. J Clin Endocrinol Metab (1986) 1.13

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene (2001) 1.12

Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab (1997) 1.11

Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology (1988) 1.08

MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci (1999) 1.05

Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer (1999) 1.03

Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res (1997) 1.03

Neurofibromatosis of the bladder. Scand J Urol Nephrol (1996) 1.02

Risk of cancer and exposure to gasoline vapors. Am J Epidemiol (1997) 1.02

Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. Acta Ophthalmol Scand (1996) 1.01

Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab (1999) 1.00

Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues. Proc Natl Acad Sci U S A (1987) 1.00

Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol (1998) 0.99

Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res (2000) 0.99

Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J Histochem Cytochem (1998) 0.98

Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr (2000) 0.98

Biological monitoring of occupational exposure to low levels of benzene. Scand J Work Environ Health (1992) 0.97

Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand (2000) 0.97

Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. Diagn Mol Pathol (1997) 0.96

Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism. J Clin Endocrinol Metab (2002) 0.96

Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. Br J Cancer (2004) 0.96

Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab (2000) 0.95

Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer (1996) 0.94

Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab (1993) 0.94

Serum lipid concentrations and growth characteristics in 12-year-old children born small for gestational age. Pediatr Res (2000) 0.94

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. Br J Cancer (2006) 0.94

Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 alpha-hydroxylase/17,20-lyase) in cultured human fetal adrenal cells. J Clin Endocrinol Metab (1987) 0.93

Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin Endocrinol (Oxf) (1996) 0.92

Genotoxic effects and chemical compositions of four creosotes. Mutat Res (1992) 0.92

High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery. Lung Cancer (2001) 0.92

Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy. Pediatr Res (1996) 0.91

Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab (2001) 0.91

Inhibition by cycloheximide of ACTH-induced internal differentiation of mitochondria in cortical cells in tissue cultures of fetal rat adrenals. Anat Rec (1971) 0.89

Effects of paternal occupational exposure on spontaneous abortions. Am J Public Health (1991) 0.89

Excess lung cancer among workers exposed to lead. Scand J Work Environ Health (1995) 0.89

Gastric inflammation is enhanced in children with CagA-positive Helicobacter pylori infection. Pediatr Infect Dis J (1999) 0.88

Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and invasion. Oncogene (2010) 0.88

Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency. J Endocrinol Invest (2000) 0.88

Risk of enzyme allergy in the detergent industry. Occup Environ Med (2000) 0.88

A clinically useful method for detecting gonadotropins in children: assessment of luteinizing hormone and follicle-stimulating hormone from urine as an alternative to serum by ultrasensitive time-resolved immunofluorometric assays. Pediatr Res (1994) 0.87

EGF receptor and its ligands, EGF and TGF-alpha, in developing and neoplastic human odontogenic tissues. Int J Dev Biol (1993) 0.87

Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol (2000) 0.87

Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy. J Heart Lung Transplant (1994) 0.87

Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors. Endocr Res (2004) 0.87

Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis. J Clin Endocrinol Metab (2001) 0.86

Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. J Intern Med (2010) 0.86

Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab (1997) 0.86

DNA methylation affects cell proliferation, cortisol secretion and steroidogenic gene expression in human adrenocortical NCI-H295R cells. J Mol Endocrinol (2004) 0.86

A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats. J Periodontol (2001) 0.85

Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. J Endocrinol (2000) 0.85

Benign premature adrenarche: clinical features and serum steroid levels. Acta Paediatr Scand (1983) 0.85

Cell association and surface features in cultures of juvenile rat seminiferous tubules. Anat Rec (1976) 0.85

Cell-specific expression of manganese superoxide dismutase protein in the lungs of patients with respiratory distress syndrome, chronic lung disease, or persistent pulmonary hypertension. Pediatr Pulmonol (2001) 0.85

Interferon-gamma inhibits steroidogenesis and accumulation of mRNA of the steroidogenic enzymes P450scc and P450c17 in cultured porcine Leydig cells. Mol Endocrinol (1989) 0.85

Congenital complete heart block in the fetus: hemodynamic features, antenatal treatment, and outcome in six cases. Pediatr Cardiol (2001) 0.84

Transcription factor GATA-4 is expressed in pediatric yolk sac tumors. Am J Pathol (1999) 0.84

Low levels of sex hormone--binding globulin in obese children. J Pediatr (1985) 0.84

H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab (1995) 0.84

cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells. J Mol Endocrinol (2004) 0.84

Ipsilateral breast recurrence after breast conserving surgery in patients with small (≤ 2cm) breast cancer treated with modern adjuvant therapies. Eur J Surg Oncol (2010) 0.83

Risk of nervous system cancer among workers exposed to lead. J Occup Environ Med (1996) 0.83